Begin main content

netupitant / palonosetron

Last Updated: December 11, 2017
Result type: Reports
Project Number: SR0548-000
Product Line: Common Drug Review

Generic Name: netupitant / palonosetron

Brand Name: Akynzeo

Manufacturer: Purdue Pharma

Indications: Nausea and vomiting (chemotherapy induced) prevention

Submission Type: New Combination

Project Status: Received

Biosimilar: No

Fee Schedule1: Pending

Submit Feedback

Key Milestones2

Call for patient input posted3November 16, 2017
Patient group input closed3January 12, 2018
Patient input summary sent for review to patient input groups-
Patient group comments on input summary closed-
Submission receivedDecember 08, 2017
Submission accepted for reviewDecember 22, 2017
Review initiated-
Draft CDR review report(s) sent to applicant-
Comments from applicant on draft CDR review report(s) received-
Redaction requests from applicant on draft CDR review report(s) received-
CDR review team's comments on draft CDR review report(s) sent to applicant-
Canadian Drug Expert Committee (CDEC) meeting-
CDEC recommendation & redacted CDR review report(s) sent to applicant and drug plans-

Tags

cancer, digestive system